ISTITUTO EUROPEO DI ONCOLOGIA SRL
- Country
- Italy
- Type
- Beneficiary
- Website
- www.ieo.it
- Grants received
- 68
Funding record
- 68 grants on record
- €31,187,843.41 awarded in total
- 2008–2025 span of the record
Grants recorded here are the ones our sources publish, and the total is the sum of those. It is not a statement of this organisation's total funding.
Programmes
- Seventh Framework Programme
- Horizon Europe Framework Programme
- European Research Council
- Horizon 2020 Framework Programme
22 further grants are on record without a programme named by the source, or under a programme outside the largest shown here.
Frequent partners
Organisations this one has been funded alongside on two or more projects. A single shared consortium is not counted: the largest here has 195 members, and being on one list together is not a collaboration.
- THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE
- UNIVERSITA DEGLI STUDI DI MILANO
- EUROPEAN MOLECULAR BIOLOGY LABORATORY
- KOBENHAVNS UNIVERSITET
- INSTITUT CURIE
- KAROLINSKA INSTITUTET
- FUNDACIO CENTRE DE REGULACIO GENOMICA
- FUNDACION SECTOR PUBLICO ESTATAL CENTRO NACIONAL INVESTIGACIONES ONCOLOGICAS CARLOS III
Calls from this organisation
No published calls from this organisation.
Grants received
- Exploring silencer functions via their associated chromatin factors
- Understanding Nanoparticle Transport Mechanisms in the Melanoma Microenvironment via a Tumor-on-a-Chip Approach
- UNCAN-CONNECT: Decentralized Collaborative Network for Advancing Cancer Research and Innovation
- Understanding and addressing LATE-effects of treatment of AYA cancer survivors with AI-based digital phenotyping and non-invasive holistic approach
- Development and validation of a pan-cancer neutrophil biomarker test for predicting clinical benefit from immunotherapy based on flow cytometry analysis of blood samples
- iINGUT: immunotherapy on an INtegrated GUt microbiome and Tumor on-chip.
- METABOLIC REGULATION OF GENOME FUNCTION AND CELL IDENTITY
- Patient-specific Microstructural and radIobiological model for persoNalised external beam radiatIONn therapy in localised tumourS
- Targeting the Polycomb Machinery in BAP1-related Pathologies
- IBeCHANGE - ADDRESSING PSYCHOSOCIAL AND LIFESTYLE RISK FACTORS TO PROMOTE PRIMARY CANCER PREVENTION: AN INTEGRATED PLATFORM TO PROMOTE BEHAVIOURAL CHANGE
- Diagnostic HER2DX-guided treatment for patients with early-stage HER2-positive breast cancer
- PRecisIon Cancer MEdicine RepurpOsing SystEm Using Pragmatic Clinical Trials
- Impact of cell shapes on cell behaviour and fate
- Quality of Life in Oncology: measuring what matters for cancer patients and survivors in Europe
- Integrative science, Intelligent data platform for Individualized LUNG cancer care with Immunotherapy
Data source
© European Union, 2026. Source: CORDIS. Reused under Commission Decision 2011/833/EU — CC BY 4.0.
Retrieved from the source on .
Personal data of natural persons has been dissociated by quiescence.eu.
This service is not affiliated with, sponsored or endorsed by the data publishers.